Remus Pharmaceuticals Ltd (REMP)

NSE
Currency in INR
1,899.35
+66.85(+3.65%)
Closed·
REMP Scorecard
Full Analysis
Suffers from weak gross profit margins
REMP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,872.001,900.00
52 wk Range
1,591.252,834.75
Key Statistics
Edit
Bid/Ask
1,877.35 / 1,929.00
Prev. Close
1,899.35
Open
1,900
Day's Range
1,872-1,900
52 wk Range
1,591.25-2,834.75
Volume
1.3K
Average Volume (3m)
3.56K
1-Year Change
-1.69%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
REMP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Providers & Services industry
No news in this category
Looks like there are no results in this news category

Remus Pharmaceuticals Ltd Company Profile

Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceutical finished formulations and products in India and internationally. It is involved in trading of active pharmaceutical ingredient, as well as provides technical consultancy services to various distributors and contract manufacturing services. The company offers capsule, cream, eye drop, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, and tablets. It has operations in Bhutan, Bolivia, Chile, Costa Rica, Cuba, the Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong Kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, and Vietnam. The company was formerly known as Remus Pharmaceuticals Private Limited and changed its name to Remus Pharmaceuticals Limited in January 2023. Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.

Employees
48
Market
India

Compare REMP to Peers and Sector

Metrics to compare
REMP
Peers
Sector
Relationship
P/E Ratio
37.4x25.4x−0.5x
PEG Ratio
-0.070.00
Price/Book
11.1x2.7x2.6x
Price / LTM Sales
2.5x2.3x2.9x
Upside (Analyst Target)
-64.7%53.0%
Fair Value Upside
Unlock3.1%8.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 50.73%
Dividend Yield
0.11%
Industry Median 0.71%
Annualised payout
2.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 09, 2024
EPS / Forecast
23.78 / --
Revenue / Forecast
2.73B / --
EPS Revisions
Last 90 days

FAQ

What Is the Remus Pharmaceuticals (REMP) Stock Price Today?

The Remus Pharmaceuticals stock price today is 1,899.35

What Stock Exchange Does Remus Pharmaceuticals Trade On?

Remus Pharmaceuticals is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Remus Pharmaceuticals?

The stock symbol for Remus Pharmaceuticals is "REMP."

Does Remus Pharmaceuticals Pay Dividends? What’s The Current Dividend Yield?

The Remus Pharmaceuticals dividend yield is 0.11%.

What Is the Remus Pharmaceuticals Market Cap?

As of today, Remus Pharmaceuticals market cap is 11.19B.

What Is Remus Pharmaceuticals's Earnings Per Share (TTM)?

The Remus Pharmaceuticals EPS (TTM) is 50.73.

From a Technical Analysis Perspective, Is REMP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.